Article info

Download PDFPDF
Question 1: In infant botulism, is equine-derived botulinum antitoxin (EqBA) an effective alternative therapy to human-derived botulinum immune globulin (BIG)?

Authors

  1. Correspondence to Mr. Joseph Moneim, University of Cambridge School of Clinical Medicine, Cambridge CB2 0SP, UK; jm946{at}cam.ac.uk
View Full Text

Citation

Moneim J
Question 1: In infant botulism, is equine-derived botulinum antitoxin (EqBA) an effective alternative therapy to human-derived botulinum immune globulin (BIG)?

Publication history

  • Received May 10, 2018
  • Revised June 27, 2018
  • Accepted June 27, 2018
  • First published July 14, 2018.
Online issue publication 
August 16, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.